Obesity risk is associated with altered cerebral glucose metabolism and decreased μ-opioid and CB1 receptor availability.
Kantonen T, Pekkarinen L, Karjalainen T, Bucci M, Kalliokoski K, Haaparanta-Solin M, Aarnio R, Dickens AM, von Eyken A, Laitinen K, Houttu N, Kirjavainen AK, Helin S, Hirvonen J, Rönnemaa T, Nuutila P, Nummenmaa L.
Kantonen T, et al. Among authors: bucci m.
Int J Obes (Lond). 2022 Feb;46(2):400-407. doi: 10.1038/s41366-021-00996-y. Epub 2021 Nov 2.
Int J Obes (Lond). 2022.
PMID: 34728775
Free PMC article.